French HAS recommends use of Axumin in PET imaging of suspected recurrent prostate cancer

07:07 EDT 5 Oct 2018 | Compelo Medical Devices

Axumin has been recommended to be included on the list of medicines approved in France for hospital use, in line with its European indication. Axumin is a new

The post French HAS recommends use of Axumin in PET imaging of suspected recurrent prostate cancer appeared first on Compelo Medical Devices.

More From BioPortfolio on "French HAS recommends use of Axumin in PET imaging of suspected recurrent prostate cancer"